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Abstract 
Background: The burden of malaria and anaemia in pregnancy remains high despite the availability of proven effica-
cious antenatal care interventions. Sub-optimal uptake of the interventions may be due to inadequate active par-
ticipation of pregnant women in their antenatal care. It was hypothesized that providing opportunities for pregnant 
women to improve upon active participation in their antenatal care through malaria and anaemia point-of-care test-
ing would improve adherence to ANC recommendations and interventions and lead to better pregnancy outcomes.
Methods: Fourteen antenatal clinics in the Ashanti region of Ghana were randomized into intervention (pregnant 
women participating in their care plus current routine care) and control (current routine care) arms. Pregnant women 
attending the clinics for the first time were recruited and followed up until delivery. Haemoglobin levels and malaria 
parasitaemia were measured at baseline, 4–8 weeks after recruitment and at 36–40 weeks gestation. Birth weight and 
pregnancy outcomes were also recorded.
Results: The overall mean age, gestational age and haemoglobin at baseline were 26.4 years, 17.3 weeks and 110 g/l, 
respectively, with no significant differences between groups; 10.7% had asymptomatic parasitaemia; 74.6% owned 
an ITN but only 48.8% slept under it the night before enrolment. The adjusted risk ratio by 8 weeks follow up and at 
36–40 weeks gestation in the intervention versus the control was 0.97 (95% CI 0.78–1.22) and 0.92 (95% CI 0.63–1.34) 
for anaemia and 1.17 (95% CI 0.68–2.04) and 0.83 (95% CI 0.27–2.57) for parasitaemia. The adjusted risk ratio for low 
birth weight was 0.93 (95% CI 0.44–1.97) and for pregnancy complications (abortions, intrauterine fetal deaths and still 
births) was 0.77 (95% CI 0.17–3.52) in the intervention group versus controls.
Conclusion: Although its potential was evident, this study found no significant beneficial effect of women partici-
pating in their malaria and haemoglobin tests on pregnancy outcomes. Exploring factors influencing health worker 
compliance to health intervention implementation and patient adherence to health interventions within this context 
will contribute in future to improving intervention effectiveness.
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Background
Malaria and anemia [hemoglobin (Hb) < 110  g/l] dur-
ing pregnancy in sub-Saharan Africa remain a concern 
despite proven efficacious antenatal care (ANC) inter-
ventions. Recommended ANC interventions include 
Intermittent preventive treatment of malaria during 
pregnancy (IPTp) using Sulfadoxine–pyrimethamine 
(SP), the use of insecticide-treated bed nets (ITN) and 
ensuring effective case management of malaria illness 
and anaemia [1]. ANC coverage in Ghana has improved 
over the last two and a half decades with more than 95% 
of pregnant women attending ANC clinics at least once 
during their pregnancy and 87% four or more times [2]. 
It is expected that as pregnant women visit the clinics 
they receive all these efficacious ANC interventions but 
their pregnancy outcomes show otherwise. In Ghana, 
anaemia and asymptomatic malaria prevalence and their 
detrimental effects during pregnancy continue to be of 
public health concern. Almost 50% of pregnant women 
at term (36–40 weeks gestation) and 12–36% of women 
at 32  weeks gestation and above, have asymptomatic 
malaria parasitaemia [3–5]. Eleven percent of babies 
born are of low birth weight [3] and ITN use during preg-
nancy is only 32%. Current national statistics show that 
68% of pregnant women received two or more doses of 
IPTp. Fifty-nine percent of them reported taking their 
iron supplements for 3 months or more [2]. Factors that 
contribute to low intervention effectiveness include inac-
cessibility or unavailability of ANC clinics, unavailabil-
ity of resources needed for intervention implementation 
and lack of adherence of ANC staff and pregnant women 
to these interventions [6]. Health system issues such as 
unclear policy and guidance, stock outs, user fees, poor 
organization leading to poor quality of care, poor health-
care provider performance as well as factors concern-
ing pregnant women such as poor timing of ANC clinic 
visits, education, age, marital status, knowledge about 
malaria and IPTp, socio-economic status and parity have 
been identified as key determinants to the uptake of IPTp 
and ITN during antenatal care [7].
The focus of efforts to enhance effectiveness of ANC 
interventions has mainly been on improving health ser-
vices for better health outcomes. While this occurs 
mainly in the clinical settings, evidence has also shown 
that community-based health intervention packages 
involving health personnel such as community health 
workers and community health nurses can improve 
maternal and child survival [8, 9]. Encouraging patients 
to actively participate in their healthcare leads to better 
health outcomes [10, 11] through improved adherence 
to or uptake of health interventions [12, 13]. Encourag-
ing patients to take part in their health care decisions is 
considered ‘a sign of valuing humanity and the individu-
ality of the patient,’ a legal right of the patient as well as 
an international gold standard for healthcare systems’ 
[14]. Although this concept has been applied to some 
aspects of patient care including decision-making dur-
ing medical consultation, patient safety and the manage-
ment of some chronic diseases [15–17], little is known 
about its usefulness in antenatal care. Only a few stud-
ies have targeted strategies aimed at improving adher-
ence of pregnant women to ANC interventions. Mbonye 
and colleagues have showed that by creating awareness 
about IPTp and its importance and improving health 
worker-pregnant woman trust, pregnant women can be 
influenced to improve their adherence to scheduled ANC 
visits, 2 doses of IPTp and health facility-based delivery 
[18] albeit not through active participation.
This study hypothesized that when pregnant women 
actively participate in their ANC, this would improve 
their adherence and hence uptake of ANC interven-
tions translating eventually into better health outcomes 
(Fig.  1). This concept was tested in this study in rela-
tion to the control of malaria and anaemia in pregnancy. 
Active participation in this study means allowing preg-
nant women to see the conduct and results of their point-
of-care tests for malaria and anaemia and be involved 
with the interpretation of the test results so as to influ-
ence their decision to adhere to ANC treatments and rec-
ommendations given at the ANC.
Package              Means of distribu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Fig. 1 Conceptual framework for pregnant women’s active participation in their antenatal care (Adapted from Campbell and Graham [33])
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Methods
Study area and population
The trial was conducted in the Ejisu-Juaben municipal-
ity and the Sekyere-East district of the Ashanti region 
of Ghana (Fig.  2) from September 2012 to April 2014. 
These two areas lie adjacent to each other in Ghana’s for-
est region. The Sekyere-East district is predominantly 
rural while the Ejisu-Juaben municipality has more 
Fig. 2 The Sekyere-East district and Ejisu-Juaben Municipality, Ashanti region, Ghana
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semi-urban areas. There are a total of four government 
hospitals in both areas, which serve as referral points 
for smaller health centres, clinics and maternity homes 
offering antenatal care. In 2011, antenatal care cover-
age in the Ejisu-Juaben municipality was 96.1% with an 
average of 3.7 visits per woman [19] while that of the 
Sekyere-East district was 70.6% with an average of 4.3 
visits per woman [20]. The prevalence of low birth weight 
(birth weight of less than 2500 g) was 14.2 and 11.9% in 
the Ejisu-Juaben municipality and Sekyere-East district 
respectively. Malaria was reported as the topmost reason 
for outpatient attendance in both areas [19, 20].
All pregnant women of all parities who were visiting 
the ANC clinics in the two areas for the first time for 
their current pregnancy were invited to be part of the 
study according to the eligibility criteria found in Box 1.
Box 1 Eligibility criteria
Inclusion criteria Exclusion criteria
First time ANC clinic visit for cur-
rent pregnancy
Pregnancy up to 32 weeks gesta-
tion
Hb ≥ 70 g/l
Willing to participate and give her 
consent
Known history of sickle cell disease, 
glucose-6-phosphate dehydro-
genase deficiency, HIV/AIDS or 
tuberculosis
Presence of significant illness at time 
of screening, including severe 
anaemia
Study design
This was a cluster randomized controlled trial with the 
ANC clinic being the unit of randomization. Eighteen 
eligible ANC clinics in the two districts were mapped—
using the Global Positioning System to determine their 
spatial locations and distances between them. An ANC 
clinic was eligible if registered 10 or more new preg-
nant women in a month, offered current routine antena-
tal care services and maternity services. A priori, it was 
decided that chosen clinics needed to be at least 1.5 km 
apart so as to reduce the risk of pregnant women cross-
ing over from one ANC clinic to the other during the 
trial. Based on this, fourteen out of the 18 ANC clinics 
were finally selected and randomized into intervention 
and control clinics (Fig. 3) and stratified by the number 
of registrants (newly booked ANC attendants) per month 
(large being 20 or more and small being less than 20). A 
statistician who was independent of the trial performed 
the randomization using Stata 11 software (StataCorp, 
College Station, Texas). Each clinic was assigned a unique 
two-digit code number, which was used to help iden-
tify the pregnant women as well and indicated whether 
they were in the intervention or the control arm of the 
study. The randomization of the ANC clinics into either 
the intervention or control arm was not disclosed to 
the clinic heads and staff during the period of the trial. 
Table 1 summarizes the features of ANC clinics that were 
included in the trial.
Sample size
A total of 93 women per ANC clinic was deemed suf-
ficient to detect a 30% decrease in the prevalence of 
anaemia from 45% [3, 21], with a power of 80 at 95% 
confidence interval and assuming a co-efficient of varia-
tion of 0.15 and an estimated 20% loss to follow up using 
the formula by Hayes and Bennet [22]. The choice to use 
anaemia prevalence over parasitaemia prevalence for 
sample size estimation was informed by
a. Reduction in anaemia being the final biological out-
come along the pathway of interest in this interven-
tion and
b. Anaemia prevalence gives a reasonable number of 
ANC clinics and pregnant women to be recruited 
within the number of ANC clinics available in the 
study area as well as time and budgetary allocation 
for the trial.
The intervention
Table 2 summarizes routine recommended ANC services 
offered in ANC clinics in the study area. These services 
were carried out in the control and intervention ANC 
clinics. In addition in the intervention clinics, pregnant 
women were encouraged to actively participate in anae-
mia and malaria control aspects of antenatal care using 
the rapid diagnostic test (RDT), Haemoglobin Colour 
Scale (HCS) and a pictorial guide (Additional file  1) for 
malaria and anaemia in pregnancy in the intervention 
arm. The pictorial guide consists of a series of sketched 
pictures that depict the causes, signs and symptoms, 
effects and prevention of malaria and anaemia in preg-
nancy. It was developed purposely for this study with 
the help of antenatal care staff in an adjacent district to 
the study areas to help provide basic and simple health 
education on malaria and anaemia in pregnancy to the 
women. The First Response Malaria HRP-2 RDT and the 
WHO HCS were used in this trial.
The intervention was implemented as described below:
1. During consultation, ANC staff conducted the RDT 
and HCS tests with the pregnant women using a sin-
gle finger-tip prick for blood.
2. The pregnant women were invited to see the tests 
being conducted and the results were interpreted 
with them.
3. The pregnant women were then encouraged to ask 
questions concerning the tests and the results.
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Fig. 3 Spatial distribution of antenatal clinics for cluster randomized controlled trial
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4. ANC staff used the pictorial guide to provide more 
information about malaria and anaemia in pregnancy 
by asking the pregnant women to look at a series of 
pictures in the guide and give meaning to them.
5. ANC staff then gave health advice and treatments to 
the pregnant women based on the test results. Health 
advice included the use of ITN, adhering to iron and 
folic acid supplementation and anti-malarial treat-
ment, healthy eating and regular ANC clinic attend-
ance.
ANC staff members in the intervention clinics were 
trained in a 1-day workshop to use the RDT, HCS and 
pictorial guide to facilitate pregnant women’s active par-
ticipation in their antenatal care. All pregnant women 
that attended ANC in the intervention clinics had the 
intervention administered even if they were not eligible 
according to the eligibility criteria (Box 1) to be enrolled 
in the trial. Active participation in their ANC occurred at 
each visit of the pregnant women until delivery.
Data collection for assessment of intervention effect
The following trial procedures were undertaken for 
women in both arms. Enrolment of pregnant women 
occurred simultaneously in all 14 ANC clinics between 
September 2012 and December 2013 while follow up was 
till the end of April 2014.
Screening, enrolment and baseline data
1. Pregnant women were screened by trained research 
assistants using the eligibility criteria (Box  1) for 
enrolment into the study.
2. Enrolled pregnant women had their socio-demo-
graphic, obstetric and medical histories and ITN use 
recorded.
3. The pregnant women were then allowed to go 
through their antenatal care.
4. After their antenatal care, blood samples were taken 
for the measurement of Hb using 301 Hemocue™ 
analysers (HemoCue, Angelhom, Sweden) and blood 
slides were done for malaria parasites determination 
later using microscopy.
5. IPTp administered was recorded.
Follow‑up
1. Follow-up was at 4–8  weeks after enrolment and 
prior to delivery at 36–40  weeks gestation as the 
women visited the ANC clinic.
2. At these follow-up visits, blood samples for Hb and 
malaria parasite determination were taken again after 
they had gone through their ANC.
3. At 36–40  weeks gestation, pregnant women were 
administered questionnaires to assess their level of 
adherence to iron and folic acid supplementation and 
their knowledge about malaria and anaemia in preg-
nancy. Adherence to iron and folic acid supplementa-
tion was measured as a proxy for adherence to ANC 
recommendations or health advice for malaria and 
anaemia using a visual analogue scale (Additional 
file 2).
4. At delivery, the birth weight was recorded. Antena-
tal and maternity registers were checked regularly for 
women who had reported any adverse outcome of 
Table 1 Features of ANC clinics included in trial by arm
Feature Number of ANC clinics
Intervention Control
Location
 Semi-urban 3 4
 Rural 4 3
Type
 Hospital 2 2
 Health centre 3 3
 Community clinic 1 1
 Maternity home 1 1
Head of clinic
 Midwife 6 7
 Physician assistant 1 0
Routine ANC services offered 7 7
Delivery services offered 7 7
Table 2 Recommended components of routine antenatal care [34]
History taking Medical and obstetric history
Physical examination Blood pressure, weight, height, temperature measurements
Obstetric examination Symphisio-fundal height measurement, foetal viability
Laboratory tests Haemoglobin concentration, malaria parasite, Routine urine and stool examination, blood group, sickling, 
VDRL, HIV
Treatments and immunizations SP-IPTp, Tetanus toxoid, ACT for malaria, folic acid and iron supplementation, de-worming
Health education and recommendations ITN use and malaria prevention, dietary, scheduled ANC visit, birth preparedness, danger signs, adherence to 
medicines, family planning, new born care, post-natal care
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their pregnancies and were recorded throughout the 
study period.
Additional information on the implementation fidelity 
of the intervention was collected to help with the inter-
pretation of the trial results. Non-participatory observa-
tions of ANC sessions and exit interviews with pregnant 
women were conducted in the 9th month of the trial. A 
trained independent observer used a 10-item checklist 
(Additional file 3) to observe whether the RDT, HCS and 
pictorial guide were being used accordingly for the active 
participation of the pregnant women.
Short exit interviews were also conducted with up to 
5 pregnant women per ANC clinic on the same day of 
observations to ascertain the processes they had been 
through during their ANC according to a 12-item check-
list (Additional file 4). The women were shown the RDT, 
HCS and pictorial guide and asked to confirm or not 
whether they were used during their ANC for their active 
participation.
Data handling and analysis
Data were collected using a pre-designed case report 
form for each pregnant woman. All data were double 
entered using Microsoft Access 2007 computer software 
and discrepancies corrected by manual crosschecking 
with the case report forms. After data were cleaned, they 
were analysed using Stata version 13 (StataCorp, College 
Station, Texas).
Descriptive statistics was used to describe the pregnant 
women at the individual and ANC clinic levels and any 
imbalances in covariates and potential confounders iden-
tified. The intervention effect was analysed by a modified 
per protocol analysis. This meant using data available 
for all women who had successfully been followed up at 
each pre-specified time point regardless of whether the 
woman had all measurements recorded for all the time 
points or not. Assessment of the intervention effect was 
done at the ANC clinic level as follows: (1) Estimating 
risks of the endpoints (malaria parasitaemia and anae-
mia prevalence, low birth weight and sub-optimal preg-
nancy outcomes-abortions, intrauterine deaths and still 
births) for each antenatal clinic. (2) Finding the mean risk 
per arm. (3) Comparing the means using the student T 
test per arm as risk ratios. All analyses were adjusted for 
baseline parasitaemia and anaemia, gestation at enrol-
ment, maternal age, educational level, ITN use, parity 
and IPTp received.
Data for knowledge of pregnant women about malaria 
and anaemia in pregnancy, adherence to iron and folate 
supplementation and intervention implementation fidel-
ity were also analysed according to Additional files 5, 6 
and 7 and are reported in Tables 7 and 8, respectively.
Results
Participant flow throughout the study
Figure 4 and Table 3 show the participant flow through-
out the study and the number of women enrolled per 
ANC clinic respectively. At 4–8  weeks after enrolment, 
a higher number, 524 out of 818 (64.1%) were followed 
up in the intervention arm compared with 479 out of 845 
(56.7%) in the control arm. Slightly higher numbers of 
women were followed up in the intervention compared 
to the control arm prior to delivery and at delivery: 429 
(52.4%) in intervention compared to 426 (50.4%) in the 
control arm prior to delivery and 499 (61%) in the inter-
vention compared to 497 (60.8%) in the control arm. 
Characteristics of women at recruitment
Tables 4 and 5 summarize the baseline characteristics of 
the pregnant women at individual and ANC clinic levels 
respectively. The mean age of the women was 26.4 years 
with approximately half of the women in the 20–29 year 
range (53.7%). Almost 70.0% had given birth to at least 
one child and more than 50.0% had three or more chil-
dren. Most of the women attended their first ANC clinic 
in the first and second trimesters; those attending in the 
third trimester accounting for less than 13.0%. Overall, 
47.2% of the women were anaemic (Hb < 11.0 g/dl) while 
10.7% had malaria parasitaemia. A total of 74.6% claimed 
ownership of bed nets but only 48.8% had slept under it 
the night before their enrolment Baseline imbalances 
existed between the two arms with regards to the wom-
en’s gravidity, parity, ITN ownership and use. Women in 
the control arm had higher gravidity, parity, ITN own-
ership and use compared to those in the intervention 
group. The mean Hb, malaria parasitaemic densities, age 
and gestational age at enrolment were however similar in 
both arms.
Study outcomes
The intervention effect is summarized in Table 6. Gener-
ally, malaria parasitaemia prevalence decreased in both 
study arms by the end of pregnancy to less than 6.0% 
compared to the baseline value of 10.7%. Anaemia preva-
lence however saw an increase to slightly over 50.0% in 
the control arm while that in the intervention arm virtu-
ally saw no change over the baseline value of 47.2%.
The risk of maternal anaemia did not vary signifi-
cantly between the two groups during pregnancy. At 
4–8  weeks after enrolment, the risk of anaemia was 
reduced marginally by 3.0% in the intervention group 
compared to the control [adjusted risk ratio (ARR) 
0.97; 95% CI 0.78–1.22] and by 8.0% prior to delivery 
(ARR 0.92; 95% CI 0.63–1.64). Similarly, there was no 
significant difference between the groups with regards 
to the risk of malaria parasitaemia during pregnancy. 
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At 4–8  weeks after enrolment, the intervention group 
appeared to have a higher risk of parasitaemia of 17.0% 
(ARR 1.17; 95% CI 0.68–2.04) compared to the control 
group but prior to delivery, the risk of parasitaemia had 
reduced by 17.0% in the intervention arm compared 
to the control group (ARR 0.83; 95% CI 0.27–2.57). 
The risk of low birth weight and sub-optimal preg-
nancy outcomes did not vary significantly between the 
14 ANC clinics selected for randomisaon in trial
7 ANC clinics randomised to 
intervenon arm
7 ANC clinics randomised 
to control arm
7 ANC clinics, 847 pregnant 
women screened
7 ANC clinics, 858 pregnant 
women screened
7 ANC clinics, 818 pregnant 
women enrolled
7 ANC clinics, 845 pregnant 
women enrolled
7 ANC clinics, 524 pregnant 
women followed up at 4-8 
weeks aer enrolment
7 ANC clinics, 479 pregnant 
women followed up at 4-8
weeks aer enrolment
7 ANC clinics, 429 pregnant 
women followed up at 36-40
weeks gestaon
7 ANC clinics, 426 pregnant 
women followed up at 36-40
weeks gestaon
13 excluded
Hb < 7g/dl 4
Not willing to aend all ANC here 3
Known SCD, HIV 3         
Gestaon > 32 weeks 0
Not first me aendance                0 
Not willing to parcipate                 3
29 excluded
Hb < 7g/dl 4
Not willing to aend all ANC here 6
Known SCD, HIV 2          
Gestaon > 32 weeks 4         
Not first me aendance                 2    
Not willing to parcipate 11
7 ANC clinics, 499 deliveries 
followed up










Fig. 4 CONSORT diagram showing the flow of participants throughout the trial
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study groups although low birth weight reduced by 
7.0% (ARR 0.93; 95% CI 0.44–1.97) in the intervention 
group compared to the control and the risk of sub-opti-
mal pregnancies reduced by 23.0% (ARR 0.77; 95% CI 
0.17–3.52).
Discussion
This was a pragmatic cluster randomized controlled trial 
designed to investigate the effectiveness of pregnant 
women’s active participation in their antenatal anaemia 
and malaria point-of-care testing in improving pregnancy 
outcomes. The study showed a potential of improv-
ing maternal and pregnancy outcomes since the risk of 
malaria parasitaemia, anaemia, low birth weight and 
sub-optimal pregnancies appeared reduced in the inter-
vention arm compared to the control arm by the end of 
pregnancy although not significantly.
A limitation identified in this study is more than 30% 
loss to follow-up at each time point in both arms (Fig. 4). 
Also, an assumption of a 30% intervention effect based 
on documented effects of patient participation in previ-
ous studies [23–25] may not have been applicable to our 
study and may have also contributed to reduced power to 
robustly detect significant benefit.
The nature of the trial, being pragmatic, did not call 
for active follow up into the communities and this may 
have contributed to a reduced power to detect signifi-
cant intervention effect. Pregnant women’s ANC seeking 
behaviour may be influenced by numerous factors includ-
ing the educational level of the woman and her husband, 
distance to the clinic from their homes, direct (pay-
ment for some services at the clinic) and indirect costs 
(transportation, food to eat and time spent to seek care), 
complacency among elder women, and women’s previous 
experiences with ANC and the staff [26–28]. Although 
these factors were not explored in this current study, they 
may have contributed to the loss to follow up. In order to 
achieve the maximum rate of data capture as the women 
attended their subsequent ANC visits, research assistants 
were stationed at the clinics every day of the week to be 
able to identify participants for follow up at the clinics. 
It is thus likely that this may be a true reflection of what 
pertains in the study area. However understanding what 
factors affect ANC seeking behaviour in subsequent vis-
its in the study area may be necessary to help improve 
ANC re-attendance.
The intervention may have been responsible for the 
higher number of women re-attending the 4–8  weeks 
after recruitment follow-up visit in the intervention arm 
compared to the control arm (Fig.  4). Women in the 
intervention arm may have been curious to see whether 
there had been changes in their Hb and malaria parasi-
taemia levels after their first visit, hence motivated to 
visit the clinic at their scheduled date, accounting for 
the higher numbers. This may also have accounted for 
the higher risk of parasitaemia detected in the interven-
tion arm compared to the control arm at this time point 
as a higher number of women were tested compared to 
the control arm. But this motivation was not enough to 
sustain attendance during pregnancy with, both arms 
recording similar reduced attendance at term and at 
delivery. Other factors like the age, parity, educational 
status, socio- economic situation and empowerment of 
the women [27, 29, 30] may be of equal importance in 
determining re-attendance to antenatal care.
The risk of parasitaemia recorded at term pregnancy in 
both arms was lower (Table 6) than has previously been 
reported [3, 4, 21]. The deployment of RDT to all ANC 
clinics by the Ghana Health Service during the time of 
the trial meant that RDT became available in the control 
ANC clinics as well. This may have reduced the effect 
of the intervention as it is possible that some ANC staff 
may have allowed the pregnant women in the control 
group to see their test results (as reported in a qualitative 
study yet to be published elsewhere). None the less, more 
widespread use of RDT may have helped identify more 
women with parasitaemia for treatment during preg-
nancy hence reducing their risk of malaria at term. The 
HCS and pictorial guides were at the intervention clinics 
only so these may have accounted for the slightly lower 
but not significant risk of anaemia observed in the inter-
vention arm compared to the control arm.
Improved adherence of pregnant women to ANC treat-
ments and recommendations was anticipated as a benefit 
of active participation of pregnant women in their care; 
however no significant difference was measured between 




ANC clinic code Number 
of women 
enrolled
ANC clinic code Number 
of women 
enrolled
Achiase 121 Kwaso 120
Nobewam 123 Onwe 122
Senchi 122 Mama Tina 118
Donyinah 119 Okaikrom 97
Yaa Asantewaa 120 Juaben 120
Effiduase 120 Huttel 121
Ejisu 120 Bomfa 120
Total 845 818
Cluster size
 Mean (range) 120.7 (119–123) 116.9 (97–122)
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intervention and control groups (Table  7). Patients’ 
adherence is a complex health behaviour, and has been 
found to be affected by a complex interplay of other fac-
tors including attitudes, beliefs and group norms; culture; 
psychological state, the patient’s involvement and partici-
patory decision making level, type of illness and co-mor-
bidity, socio-economic level, use of alternative medicine 
and stakes of proposed outcome [13, 17]. Understanding 
what factors influenced these pregnant women’s adher-
ence to ANC recommendations and treatments might 
have helped explain the results in the context of com-
plex inter-relations between patient adherence, improved 
health outcomes and intervention implementation. 
Health literacy, another factor that affects patient adher-
ence [13] was slightly but not significantly increased in 
the intervention group compared to the control group. 
This was evidenced by the higher scores of adequate 
knowledge about malaria and anaemia in pregnancy 
(Table  7) in the intervention group compared with the 
control group however this alone may not have been 
enough to positively influence the pregnant woman’s 
level of adherence.
Although patient adherence to health interventions 
is important for health intervention effectiveness, 
Table 4 Baseline characteristics of study participants at individual level
Characteristics Control (N = 845) Intervention (N = 818) Total
n % n % n %
Parity
 0 295 34.95 215 26.28 510 30.69
 1 195 23.10 191 23.35 386 23.23
 ≥ 2 354 41.94 412 50.37 766 46.09
Gravidity
 1 238 28.20 176 21.52 414 24.91
 2 189 22.39 182 22.25 371 22.32
 ≥ 3 417 49.41 460 56.23 877 52.77
Gestation at first ANC visit
 First 324 38.57 260 31.86 584 35.27
 Second 414 49.29 451 55.27 865 52.23
 Third 102 12.14 105 12.87 207 12.5
 Mean (SD) gestational age 15.93 7.12 17.08 6.74
Age group
 Under 20 125 14.81 134 16.38 259 15.58
 20–29 470 55.69 423 51.71 893 53.73
 30 and above 249 29.50 261 31.91 510 30.69
 Mean age (SD) 26.29 6.37 26.44 6.64
Educational level
 None 87 10.32 127 15.54 214 12.89
 Basic 617 73.19 611 74.79 1228 73.98
 Post basic 139 16.49 79 9.67 218 13.13
ITN ownership
 Yes 574 68.09 665 81.3 1239 74.59
ITN use
 Yes 341 40.45 470 57.46 811 48.83
IPT-SP served
 Yes 239 28.35 294 36.16 533 32.19
Anaemia
 Yes 381 45.14 403 49.27 784 47.17
 Mean haemoglobin (SD) (g/dl) 11.03 (1.46) 10.99 (1.44)
Parasitaemia
 Yes 64 7.69 111 13.70 175 10.66
 GMPD (95% CI) 653.45 (481.56–886.68) 442.76 (332.01–590.46)
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health service factors including accessibility to health-
care, availability of diagnostics and health provider 
compliance with intervention implementation [6] 
are necessary for intervention effectiveness too. In 
this study, it was assumed that financial accessibil-
ity to antenatal care was assured by the free maternal 
Table 5 Baseline characteristics of study participants at ANC clinic level
Control Intervention p value
Number of clusters (ANC clinics) 7 7
Hb
 Mean of ANC clinic summaries 11.03 10.99 0.83
 Standard deviation 0.38 0.33
 Median 11.06 11.01
 Range 10.55–11.47 10.61–11.63
Age
 Mean of ANC clinic summaries 26.29 26.40 0.83
 Standard deviation 0.92 0.98
 Median 25.88 26.11
 Range 25.22–27.54 25.07–27.89
Gestational age at enrolment (weeks)
 Mean of ANC clinic summaries 15.92 17.12 0.26
 Standard deviation 1.95 1.86
 Median 16.01 18.03
 Range 13.07–18.95 14.42–19.18
Parity
 Mean of ANC clinic summaries 1.60 1.95 0.03
 Standard deviation 0.24 0.28
 Median 1.54 1.84
 Range 1.28–2.05 1.66–2.50
Gravidity
 Mean of ANC clinic summaries 2.93 3.24 0.03
 Standard deviation 0.21 0.27
 Median 3.00 3.23
 Range 2.61–3.16 2.92–3.80
Parasite density
 Mean of ANC clinic summaries 1202.95 1625.57 0.40
 Standard deviation 601.19 1138.95
 Median 989.33 1300.00
 Range 543.33–2014 559.20–4087
Anaemia
 Mean of ANC clinic proportions 45.08 49.23 0.50
 95% CI (33.20–56.96) (40.51–57.96)
Felt unwell
 Mean of ANC clinic proportions 54.09 66.47 0.28
 95% CI (31.76–76.42) (52.02–80.92)
ITN ownership
 Mean of ANC clinic proportions 67.90 81.55 0.004
 95% CI (62.44–73.36) (73.98–89.12)
ITN use
 Mean of ANC clinic proportions 40.28 58.03 0.03
 95% CI (31.58–48.97) (42.09–73.96)
Parasitaemia
 Mean of ANC clinic proportions 9.14 15.86
 95% CI (2.93–15.36) (8.57–23.15) 0.11
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health care and delivery policy that was underway in 
the country at time of the study [31] and geographical 
accessibility by the design of the study. There was also 
constant supply of the point-of-care tests (diagnostics) 
needed throughout the study since these were provided 
by the project. Health provider compliance with inter-
vention implementation, measured during the study as 
implementation fidelity was however found to be below 
expectation (Table  8). ANC staff may have adopted 
the active participation concept with enthusiasm at 
the beginning of the trial but this was not sustained 
as evidenced by the lower than expected implementa-
tion fidelity. Health workers’ unwillingness to delegate 
power, their perceived lack of time, the type of health 
situation the health care worker is dealing with, their 
individual characteristics including their personal 
beliefs, perceptions and knowledge of the intervention, 
their specialization level, and their age and sex are 
known to influence their level of compliance [17, 32]. 
Although these factors were not explored in this study, 
some of them may have contributed to the sub-opti-
mal implementation and hence reduced intervention 
effectiveness.
Conclusion
This study has demonstrated that encouraging pregnant 
women to see and be involved with the interpretation of 
their point-of-care test results for malaria and anaemia 
has the potential to improve maternal and pregnancy 
outcomes albeit not statistically significant. It appears 
there is a rather complex inter-relation between active 
patient participation, patient adherence, intervention 
Table 6 Intervention effect on anaemia, malaria parasitaemia, low birth weight and sub optimal pregnancy outcomes
a Risk ratios adjusted for baseline parasitaemia, anaemia, gestation at enrolment, age, educational level, ITN use, IPT-SP served and parity














Anaemia at 4–8 weeks after enrolment
 Control 7 48.39 33.33–70.00
 Intervention 7 48.04 36.74–62.63 0.99 0.73–1.34 0.96 0.97 0.78–1.22 0.79
Anaemia prior to delivery
 Control 7 50.25 22.73–78.95
 Intervention 7 47.40 20.41–65.38 0.94 0.60–1.49 0.78 0.92 0.63–1.34 0.62
Malaria at 4–8 weeks after enrolment
 Control 7 6.43 1.67–12.82
 Intervention 7 6.73 2.60–11.50 1.05 0.58–1.89 0.86 1.17 0.68–2.04 0.51
Malaria prior to delivery
 Control 7 5.91 0.00–15.00
 Intervention 7 4.34 0.00–7.690 0.73 0.24–2.26 0.59 0.83 0.27–2.57 0.73
Low birth weight
 Control 7 13.18 5.41–31.48
 Intervention 7 10.81 2.44–19.74 0.82 0.38–1.78 0.59 0.93 0.44–1.97 0.84
Suboptimal pregnancy outcome
 Control 7 8.35 0.00–39.22
 Intervention 7 6.32 0.00–10.53 0.76 0.16–3.48 0.72 0.77 0.17–3.52 0.73
Table 7 Comparison of mean proportions of women’s knowledge on malaria, anaemia and adherence by arm





Adequate knowledge on anaemia Control 31.28 23.37 9.67–52.89
Intervention 43.81 35.07 11.37–76.24 0.4468
Adequate knowledge on malaria Control 40.59 27.80 14.87–66.30
Intervention 54.26 30.83 25.75–82.78 0.4005
Adequate adherence to health advice Control 34.20 23.31 12.63–55.76
Intervention 35.86 17.54 19.64–52.08 0.8822
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implementation and expected health outcomes. Explor-
ing what factors influence health worker compliance to 
health intervention implementation and patient adher-
ence to health interventions within this context will 
contribute to understanding and improving interven-
tion effectiveness and hence patient health outcomes.
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